Ensysce Historical Income Statement
| ENSC Stock | USD 0.59 0.07 10.61% |
Historical analysis of Ensysce Biosciences income statement accounts such as Interest Expense of 432.8 K or Total Revenue of 2.2 M can show how well Ensysce Biosciences performed in making a profits. Evaluating Ensysce Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ensysce Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Ensysce Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ensysce Biosciences is a good buy for the upcoming year.
Ensysce |
About Ensysce Income Statement Analysis
Ensysce Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ensysce Biosciences shareholders. The income statement also shows Ensysce investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Ensysce Biosciences Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Operating Income
Operating Income is the amount of profit realized from Ensysce Biosciences operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Ensysce Biosciences is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ensysce Biosciences. It is also known as Ensysce Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Ensysce Biosciences income statement and represents the costs associated with goods and services Ensysce Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Ensysce Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ensysce Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.At present, Ensysce Biosciences' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 9.9 M, whereas Interest Income is forecasted to decline to about 93.6 K.
| 2023 | 2024 (projected) | Interest Income | 98.6K | 93.6K | Tax Provision | 281.2K | 373.2K |
Ensysce Biosciences income statement Correlations
Click cells to compare fundamentals
Ensysce Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ensysce Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Income | 4.2M | 939.7K | 622K | 109.5K | 98.6K | 93.6K | |
| Total Revenue | 1.8M | 3.9M | 3.5M | 2.5M | 2.2M | 2.2M | |
| Operating Income | (3.3M) | (1.6M) | (19.9M) | (24.2M) | (10.7M) | (11.3M) | |
| Income Before Tax | 921.2K | (160.9K) | (29.1M) | (24.2M) | (10.6M) | (11.2M) | |
| Net Income Applicable To Common Shares | 366.0K | 4.3M | (29.9M) | (25.1M) | (22.6M) | (21.4M) | |
| Net Income | 1.5M | (938.7K) | (29.1M) | (25.0M) | (10.6M) | (11.1M) | |
| Gross Profit | (3.3M) | 2.6M | 3.5M | (17.3M) | (5.4M) | (5.6M) | |
| Other Operating Expenses | 3.3M | 1.6M | 19.9M | 24.2M | 12.9M | 11.5M | |
| Net Income From Continuing Ops | 366.0K | 4.3M | (29.1M) | (24.2M) | (12.6M) | (13.2M) | |
| Ebit | (3.3M) | (1.6M) | (19.9M) | (24.2M) | (10.7M) | (11.3M) | |
| Ebitda | (3.3M) | (1.6M) | (19.9M) | (24.2M) | (10.7M) | (11.3M) | |
| Cost Of Revenue | 3.3M | 1.4M | 151.0 | 19.8M | 7.6M | 6.2M | |
| Total Operating Expenses | 3.3M | 1.6M | 19.9M | 24.2M | 5.4M | 9.9M | |
| Total Other Income Expense Net | 4.2M | 1.5M | (9.3M) | 14.4K | 91.9K | 96.5K | |
| Income Tax Expense | (555.2K) | 777.9K | (151.0) | 753.9K | (264.0) | (250.8) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.94) | Revenue Per Share 0.274 | Quarterly Revenue Growth (0.63) | Return On Assets (1.32) | Return On Equity (4.28) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.